Approved Hospital Formulary
Add Formweb to your mobile device
Approved Hospital Formulary
Search results for:
HYDROmorphone
HYDROmorphone
| Drug Name | Form | Strength | Non-Formulary | Restricted | Renal Dosing | REMS | Therapeutic Interchange | Notes |
|---|---|---|---|---|---|---|---|---|
| Dilaudid-5 | LIQUID, ORAL | 1 mg/mL | ||||||
| HYDROmorphone HCl | SOLUTION, INJECTABLE | 1 mg/mL | ||||||
| Dilaudid | SOLUTION, INJECTABLE | 2 mg/mL | ||||||
| HYDROmorphone HCl | SOLUTION, INJECTABLE | 4 mg/mL | ||||||
| HYDROmorphone HCl | SOLUTION, INJECTABLE | 10 mg/mL | ||||||
| HYDROmorphone HCl | SUPPOSITORY, RECTAL | 3 mg | ||||||
| HYDROmorphone HCl | TABLET, ORAL | 2 mg, 4 mg |
Additional Information:
| Drug Name | Common Side Effects |
| hydromorphone |
|
Last updated: Aug. 22, 2022
- Black Box Warning: Injection: Respiratory depression risk; abuse potential
- Black Box Warning: Injection, High Potency: Opioid-tolerant patients only; Respiratory depression risk; abuse potential
- Black Box Warning: Oral, extended release: Opioid-tolerant patients only; overdose risk; abuse potential
- Black Box Warning: Oral, liquid & tablets: Abuse potential; respiratory depression; neonatal withdrawal; alcohol interaction
- Do Not Crush: Extended-release Tablet - Note: breaking, chewing, crushing, dissolving before swallowing or injecting could result in overdose
- REMS: View FDA REMS Info
- REMS: FDA Med Guide Comprehensive List
